ATE387240T1 - Peptidisch gepufferte formulierungen für elektrotransport-anwendungen und zugehörige herstellungsverfahren - Google Patents

Peptidisch gepufferte formulierungen für elektrotransport-anwendungen und zugehörige herstellungsverfahren

Info

Publication number
ATE387240T1
ATE387240T1 AT04811838T AT04811838T ATE387240T1 AT E387240 T1 ATE387240 T1 AT E387240T1 AT 04811838 T AT04811838 T AT 04811838T AT 04811838 T AT04811838 T AT 04811838T AT E387240 T1 ATE387240 T1 AT E387240T1
Authority
AT
Austria
Prior art keywords
peptidic
drug solution
manufacturing processes
associated manufacturing
transportation applications
Prior art date
Application number
AT04811838T
Other languages
English (en)
Inventor
David Rauser
Rama Padmanabhan
Joseph Phipps
Michel Cormier
Janardhanan Subramony
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ATE387240T1 publication Critical patent/ATE387240T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0448—Drug reservoir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0412—Specially adapted for transcutaneous electroporation, e.g. including drug reservoirs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Polyethers (AREA)
  • Graft Or Block Polymers (AREA)
  • Peptides Or Proteins (AREA)
  • Hydrogenated Pyridines (AREA)
  • Data Exchanges In Wide-Area Networks (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
AT04811838T 2003-11-19 2004-11-19 Peptidisch gepufferte formulierungen für elektrotransport-anwendungen und zugehörige herstellungsverfahren ATE387240T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52347003P 2003-11-19 2003-11-19

Publications (1)

Publication Number Publication Date
ATE387240T1 true ATE387240T1 (de) 2008-03-15

Family

ID=34632786

Family Applications (2)

Application Number Title Priority Date Filing Date
AT04811838T ATE387240T1 (de) 2003-11-19 2004-11-19 Peptidisch gepufferte formulierungen für elektrotransport-anwendungen und zugehörige herstellungsverfahren
AT04811757T ATE370766T1 (de) 2003-11-19 2004-11-19 Verfahren zur herstellung von polymeren pufferformulierungen für elektrotransport- anwendungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT04811757T ATE370766T1 (de) 2003-11-19 2004-11-19 Verfahren zur herstellung von polymeren pufferformulierungen für elektrotransport- anwendungen

Country Status (12)

Country Link
US (2) US20050142531A1 (de)
EP (2) EP1689489B1 (de)
JP (2) JP2007511617A (de)
KR (2) KR20070001877A (de)
AT (2) ATE387240T1 (de)
CA (2) CA2546399A1 (de)
DE (2) DE602004012143T2 (de)
DK (1) DK1684851T3 (de)
ES (1) ES2291975T3 (de)
PL (1) PL1684851T3 (de)
PT (1) PT1684851E (de)
WO (2) WO2005051485A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY28935A1 (es) 2004-06-03 2005-07-29 Alza Corp Sistema y metodo para la administracion transdermica de un anticoagulante
CN101405051A (zh) * 2006-03-21 2009-04-08 阿尔扎公司 用于药物电转运的可水化聚合酯基质
EP2101864A2 (de) * 2006-12-20 2009-09-23 ALZA Corporation Anode für den elektrischen transport eines kationischen arzneimittels
US20090105632A1 (en) * 2007-10-18 2009-04-23 Padmanabhan Rama V Electrotransport Of Lisuride

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5080646A (en) * 1988-10-03 1992-01-14 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5147296A (en) * 1988-10-03 1992-09-15 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5169382A (en) * 1988-10-03 1992-12-08 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5853383A (en) * 1995-05-03 1998-12-29 Alza Corporation Preparation for formulations for electrotransport drug delivery
WO1997012644A1 (en) * 1995-09-29 1997-04-10 Becton Dickinson And Company Improved iontophoretic reservoir apparatus
ES2202910T3 (es) * 1997-11-12 2004-04-01 Alza Corporation Composiciones de farmacos regulados para la administracion transdermica por electrotranporte.
US6039977A (en) * 1997-12-09 2000-03-21 Alza Corporation Pharmaceutical hydrogel formulations, and associated drug delivery devices and methods
WO2002089803A1 (en) * 2001-05-07 2002-11-14 Sankyo Company, Limited Composition for iontophoresis

Also Published As

Publication number Publication date
DE602004012143T2 (de) 2008-06-19
DE602004012143D1 (de) 2008-04-10
WO2005051484A1 (en) 2005-06-09
PL1684851T3 (pl) 2007-12-31
EP1684851B1 (de) 2007-08-22
DE602004008502T2 (de) 2008-01-03
KR20060130042A (ko) 2006-12-18
JP2007516962A (ja) 2007-06-28
ATE370766T1 (de) 2007-09-15
PT1684851E (pt) 2007-12-03
EP1689489B1 (de) 2008-02-27
ES2291975T3 (es) 2008-03-01
EP1689489A1 (de) 2006-08-16
EP1684851A1 (de) 2006-08-02
JP2007511617A (ja) 2007-05-10
US20050129655A1 (en) 2005-06-16
CA2546405A1 (en) 2005-06-09
DK1684851T3 (da) 2008-01-07
CA2546399A1 (en) 2005-06-09
WO2005051485A1 (en) 2005-06-09
US20050142531A1 (en) 2005-06-30
DE602004008502D1 (de) 2007-10-04
KR20070001877A (ko) 2007-01-04

Similar Documents

Publication Publication Date Title
AU2002350216A1 (en) Low equivalent weight ionomer
CR8998A (es) PRODUCCION DE TNFR-Ig Y FUSION DE PROTEINA
IL179617A0 (en) Method of stabilizing proteins
BR0317243A (pt) Vetor de expressão, célula hospedeira, métodos para produzir proteìnas il-21 e para isolar proteìna il-21 insolúvel, e, composição
IL175021A0 (en) Chromatin insulator, its preparation and use in protein expression
NZ592918A (en) Antibody formulation comprising an IL-1beta antibody and a buffer
BRPI0507856A (pt) composição farmacêutica, e, processo para preparar o anticorpo abeta
DE69942459D1 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
PT1928784E (pt) Processo e instalação para produzir biocidas sinergísticos
BRPI0413002A (pt) genes de ciclo de célula de planta e métodos de uso
AR050050A1 (es) Factores de virulencia bacteriana y sus usos
NO20030856L (no) Membranpenetrerende peptider og anvendelse av disse
ATE527378T1 (de) Antisense-modulation von p38-mitogen-aktivierter proteinkinase-expression
AR030741A1 (es) Derivados de los acidos 2-amino-2-alquil-5-heptenoico y - heptinoico utiles como inhibidores de oxido nitrico sintetasa
DE60233532D1 (de) An proteinphosphatase 2a bindende synthetische ode anwendungen
AR036640A1 (es) Formulaciones y uso de las mismas
BRPI0410861A (pt) métodos e composições para a produção de aminoácidos
ATE457352T1 (de) Subtilisin-carlsberg-proteine mit verminderter immunogenität
AU2003222717A8 (en) Streptavidin-binding peptide
ATE387240T1 (de) Peptidisch gepufferte formulierungen für elektrotransport-anwendungen und zugehörige herstellungsverfahren
WO2003060066A8 (en) Nucleic acid delivery and expression
NO20033705L (no) Fremgangsmåte for fremstilling av D-pantotensyre og/eller salter som tilsetning til dyrefôr
CY1108643T1 (el) Κυτταρικη σειρα και χρησεις της
SE0202365D0 (sv) New formulation and use thereof
AU2001240540A1 (en) Method for the manufacture of recombinant trypsin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties